BioCryst raises ORLADEYO WAC 5% to $44,484.33 per 28-day pack effective Jan 8

BIOCRYST PHARMACEUTICALS INC

ORLADEYO WAC raised from $42,366.03 to $44,484.33 per 28-day pack (150mg or 110mg).
Price increase of approximately 5% effective January 8, 2025.
The WAC increase applies to both the 150mg and 110mg capsule packs.

item 7.01

BIOCRYST PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001171843-25-000112

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.